These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16625728)

  • 1. Human participants challenges in youth-focused research: perspectives and practices of IRB administrators.
    Wagener DK; Sporer AK; Simmerling M; Flome JL; An C; Curry SJ
    Ethics Behav; 2004; 14(4):335-49. PubMed ID: 16625728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human participants challenges in youth tobacco cessation research: researchers' perspectives.
    Diviak KR; Curry SJ; Emery SL; Mermelstein RJ
    Ethics Behav; 2004; 14(4):321-34. PubMed ID: 16625727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conducting industrial and organizational psychological research: institutional review of research in work organizations.
    Ilgen DR; Bell BS
    Ethics Behav; 2001; 11(4):395-412. PubMed ID: 11838504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using our best judgment in conducting human research.
    Sieber JE
    Ethics Behav; 2004; 14(4):297-304. PubMed ID: 16622989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed consent for research on stored blood and tissue samples: a survey of institutional review board practices.
    White MT; Gamm J
    Account Res; 2002; 9(1):1-16. PubMed ID: 12705242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Institutional review board guidance on pediatric research: missed opportunities.
    Wolf LE; Zandecki J; Lo B
    J Pediatr; 2005 Jul; 147(1):84-9. PubMed ID: 16027701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent and parent perspectives on ethical issues in youth drug use and suicide survey research.
    Fisher CB
    Ethics Behav; 2003; 13(4):303-32. PubMed ID: 15000093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research consent by adolescent minors and institutional review boards.
    Mammel KA; Kaplan DW
    J Adolesc Health; 1995 Nov; 17(5):323-30. PubMed ID: 8924437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nanny state meets the inner lawyer: overregulating while underprotecting human participants in research.
    Gunsalus CK
    Ethics Behav; 2004; 14(4):369-82. PubMed ID: 16625733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empirical research on research ethics.
    Sieber JE
    Ethics Behav; 2004; 14(4):397-412. PubMed ID: 16625736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Views of the process and content of ethical reviews of HIV vaccine trials among members of US institutional review boards and South African research ethics committees.
    Klitzman R
    Dev World Bioeth; 2008 Dec; 8(3):207-18. PubMed ID: 19046258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When "minimal risk" research yields clinically-significant data, maybe the risks aren't so minimal.
    Sharp HM; Orr RD
    Am J Bioeth; 2004; 4(2):W32-6. PubMed ID: 15186687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in standards of research compensation and child assent practices: a comparison of 69 institutional review board-approved informed permission and assent forms for 3 multicenter pediatric clinical trials.
    Kimberly MB; Hoehn KS; Feudtner C; Nelson RM; Schreiner M
    Pediatrics; 2006 May; 117(5):1706-11. PubMed ID: 16651328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical research regulation: challenges to the institutional review board system.
    Straight TM
    Clin Dermatol; 2009; 27(4):375-83. PubMed ID: 19539166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinician educators' experiences with institutional review boards: results of a national survey.
    Dyrbye LN; Thomas MR; Papp KK; Durning SJ
    Acad Med; 2008 Jun; 83(6):590-5. PubMed ID: 18520468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting and referring research participants: ethical challenges for investigators studying children and youth.
    Fisher CB
    Ethics Behav; 1994; 4(2):87-95. PubMed ID: 11654930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determining risk in pediatric research with no prospect of direct benefit: time for a national consensus on the interpretation of federal regulations.
    Fisher CB; Kornetsky SZ; Prentice ED
    Am J Bioeth; 2007 Mar; 7(3):5-10. PubMed ID: 17366219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.
    Ernst AA; Fish S
    Acad Emerg Med; 2005 Nov; 12(11):1050-5. PubMed ID: 16264073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on "Family dynamics and children in medical research.
    Robinson W
    J Clin Ethics; 1996; 7(4):362-4. PubMed ID: 11644884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.